Cargando…
Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes
BACKGROUND: KCNC1 encodes Kv3.1, a subunit of the Kv3 voltage-gated potassium channels. It is predominantly expressed in inhibitory GABAergic interneurons and cerebellar neurons. Kv3.1 channelopathy has been linked to a variety of human diseases including epilepsy, developmental delay, and ataxia. C...
Autores principales: | Li, Xiaoyang, Zheng, Yongsheng, Li, Shaoyuan, Nair, Umesh, Sun, Chong, Zhao, Chongbo, Lu, Jiahong, Zhang, Victor Wei, Maljevic, Snezana, Petrou, Steven, Lin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506712/ https://www.ncbi.nlm.nih.gov/pubmed/34733949 http://dx.doi.org/10.21037/atm-21-1885 |
Ejemplares similares
-
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches
por: D’Adamo, Maria Cristina, et al.
Publicado: (2020) -
α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
por: Chiu, Wei-Hua, et al.
Publicado: (2021) -
Channelopathies
por: Kim, June-Bum
Publicado: (2014) -
SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction
por: Bryson, Alexander, et al.
Publicado: (2023) -
Genetic neurological channelopathies: molecular genetics and clinical phenotypes
por: Spillane, J, et al.
Publicado: (2016)